Bond Bausch Health Group 5.875% ( USC96729AB14 ) in USD
| Issuer | Bausch Health Group | ||
| Market price | 100 % ▲ | ||
| Country | Canada
|
||
| ISIN code |
USC96729AB14 ( in USD )
|
||
| Interest rate | 5.875% per year ( payment 2 times a year) | ||
| Maturity | 14/05/2023 - Bond has expired | ||
|
|||
| Minimal amount | 2 000 USD | ||
| Total amount | 2 666 074 000 USD | ||
| Cusip | C96729AB1 | ||
| Standard & Poor's ( S&P ) rating | B ( Highly speculative ) | ||
| Moody's rating | N/A | ||
| Detailed description |
Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products. The Bond issued by Bausch Health Group ( Canada ) , in USD, with the ISIN code USC96729AB14, pays a coupon of 5.875% per year. The coupons are paid 2 times per year and the Bond maturity is 14/05/2023 The Bond issued by Bausch Health Group ( Canada ) , in USD, with the ISIN code USC96729AB14, was rated B ( Highly speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||
Français
Italiano
Canada